1-8 of 8
Valérie Bardet
Close
Sort by
Journal Articles

Targeted Therapy in CMML: Complete Molecular Response to Sorafenib in a Patient with a FLT3-ITD Malignant Hematopoiesis

Olivier Kosmider, MD, PhD, Nicolas Chapuis, Sophie Kaltenbach, Romain Coriat, Pascaline boudou-Rouquette, Lise Willems, Virginie Chesnais, Isabelle Radford-Weiss, Valérie Bardet, Patrick Mayeux, Jerome Tamburini, Michaela Fontenay, MD, PhD, Didier Bouscary
Journal: Blood
Blood (2012) 120 (21): 4786.
https://doi.org/10.1182/blood.V120.21.4786.4786
Published: 2012
Journal Articles

Prognostic Impact of the Amount of CD34+ CD38- CD123+ Cells at Diagnosis In Acute Myeloid Leukemia: a Study From the GOELAMS

François Vergez, Alexa Green, Jérôme Tamburini, Nathalie Gallay, Murielle Roussel, Baptiste Gaillard, Aymeric Neyret, Melanie Pannetier, Nicolas Chapuis, Norbert Ifrah, Francois Dreyfus, Cécile Demur, Catherine Lacombe, Patrick Mayeux, Didier Bouscary, Stéphane Manenti, Christian Récher, MD, Valérie Bardet
Journal: Blood
Blood (2010) 116 (21): 951.
https://doi.org/10.1182/blood.V116.21.951.951
Published: 2010
Journal Articles

IκB Kinase Overcomes PI3K to Control FoxO3a Subcellular Localization in Acute Myeloid Leukemia.

Nicolas Chapuis, Sophie Park, Laurent Leotoing, Jerome Tamburini, Frederique Verdier, Valérie Bardet, Alexa Samantha Green, Fabrice Agou, Georges Bismuth, Veronique Baud, Patrick Mayeux, Catherine Lacombe, Didier Bouscary, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 478.
https://doi.org/10.1182/blood.V114.22.478.478
Published: 2009
Journal Articles

The PI3K/mTOR Inhibitor NVP-BEZ235 Is a Promising Pre-Clinical Candidate for Therapeutic Intervention in Acute Myeloid Leukemia.

Nicolas Chapuis, Jerome Tamburini, Alexandre Macone, Alexa Samantha Green, Valérie Bardet, Lise Willems, Sophie Park, Norbert Ifrah, Francois Dreyfus, MD, PhD, Sauveur-Michel Maira, Patrick Mayeux, Catherine Lacombe, Didier Bouscary, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1024.
https://doi.org/10.1182/blood.V114.22.1024.1024
Published: 2009
Journal Articles

P-ERK1/2 Is a Predictive Factor of Response to ESA Treatment in Myelodysplastic Syndromes.

Emilie Frisan, Patrycja Pawlikowska, Cécile Pierre-Eugène, Valérie Bardet, Laure Gibault, Vivian Viallon, Olivier Kosmider, Frederique Verdier, Sophie Park, Frédérique Kuhnowsky, Martine Guesnu, Catherine Lacombe, Patrick Mayeux, Francois Dreyfus, Francoise Porteu, Michaela Fontenay
Journal: Blood
Blood (2009) 114 (22): 294.
https://doi.org/10.1182/blood.V114.22.294.294
Published: 2009
Journal Articles

Protein Synthesis Escapes mTORC1 Control and Constitutes a Promising Therapeutic Target in Acute Myeloid Leukemia.

Jerome Tamburini, Alexa Samantha Green, Valérie Bardet, Nicolas Chapuis, Lise Willems, Sophie Park, Madalina Uzunov, Norbert Ifrah, Francois Dreyfus, Patrick Mayeux, Catherine Lacombe, Didier Bouscary, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 934.
https://doi.org/10.1182/blood.V112.11.934.934
Published: 2008
Journal Articles

mTORC1 Activity Is Independent of PI3K/Akt but Controlled by AMPK in Acute Myeloid Leukemia.

Alexa Samantha Green, Jerome Tamburini, Lise Willems, Nicolas Chapuis, Sophie Park, Valérie Bardet, Marc Foretz, Benoit Viollet, Norbert Ifrah, Francois Dreyfus, Patrick Mayeux, Catherine Lacombe, Didier Bouscary, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 935.
https://doi.org/10.1182/blood.V112.11.935.935
Published: 2008
Journal Articles

Autocrine IGF-1/IGF-1R Signaling Is Responsible for PI3K/Akt Constitutive Activation in Acute Myeloid Leukemia.

Nicolas Chapuis, Jerome Tamburini, Pascale Cornillet-Lefebvre, Lucile Gillot, Valérie Bardet, Lise Willems, Sophie Park, Alexa Samantha Green, Norbert Ifrah, Francois Dreyfus, Patrick Mayeux, Catherine Lacombe, Didier Bouscary
Journal: Blood
Blood (2008) 112 (11): 937.
https://doi.org/10.1182/blood.V112.11.937.937
Published: 2008